Back to search

Shiitake, Hua Gu · 2022 · Journal Article

Medium relevance

RBAC and Its Role with the Immune System.

Lentinula edodes

Immune supportGut & microbiomeLiver support
SpeciesShiitake, Hua Gu
JournalAlternative therapies in health and medicine
Year2022

Key points

  • OBJECTIVE: The study's primary objective was to identify the role of RBAC in supporting cancer therapies
  • DESIGN: The author designed an open study
  • OUTCOME MEASURES: The study measured circulating tumor cells (CTC) and tumor markers-the prostate-specific antigen (PSA) and cancer antigens 125 (CA125) 15-3 (CA15-3), and 27-29 (CA27-29) for the relevant malignancy
  • RESULTS: Twelve out of 14 participants completed the protocol, and two participants died during the study
  • Of the 12 participants completing the study, the CTC levels were reduced in 10, with a statistically significant difference between the testing at baseline and postintervention (P =.0047)
  • CONCLUSIONS: The results suggest that the product can be an effective immunomodulator that can complement conventional cancer treatment

Metadata-grounded summary

Citation abstract

CONTEXT: Rice Bran Arabinoxylan Compound (RBAC) is a trusted and proven immunomodulator made from a rice bran extract that has been enzymatically modified with an enzyme complex from the shiitake mushroom.

OBJECTIVE: The study's primary objective was to identify the role of RBAC in supporting cancer therapies.

DESIGN: The author designed an open study.

PARTICIPANTS: Participants were 14 patients who are suffering from various type of malignancies.

INTERVENTION: BRM4 capsules-a commercially available, proprietary RBAC supplement-were administered.

OUTCOME MEASURES: The study measured circulating tumor cells (CTC) and tumor markers-the prostate-specific antigen (PSA) and cancer antigens 125 (CA125) 15-3 (CA15-3), and 27-29 (CA27-29) for the relevant malignancy.

RESULTS: Twelve out of 14 participants completed the protocol, and two participants died during the study. Of the 12 participants completing the study, the CTC levels were reduced in 10, with a statistically significant difference between the testing at baseline and postintervention (P =.0047). The tumor markers of various malignancies decreased for nine out the 12 participants, and one participant experienced remission.

CONCLUSIONS: The results suggest that the product can be an effective immunomodulator that can complement conventional cancer treatment.

Citation

Pescatore F, Prestano C, Kichikova M (2022). RBAC and Its Role with the Immune System. Alternative therapies in health and medicine PMID: 35120333

Open citation